Mersana Therapeutics, Inc. (MRSN)


Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Mersana Therapeutics, Inc. chart...

About the Company

We do not have any company description for Mersana Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

255

Exchange

Nasdaq

$3M

Total Revenue

255

Employees

$380M

Market Capitalization

-2.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MRSN News

Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?

20d ago, source: Zacks.com on MSN

Curis (CRIS) shares rallied 19.5% in the last trading session to close at $16.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

7 Billion-Dollar Oncology M&As from Q1

15d ago, source: BioSpace

AbbVie’s $10.1 billion takeover of ImmunoGen paces the cancer sector in early 2024, as ADCs and radiopharmaceuticals remain ...

Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Genmab (GMAB)

9d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Legend Biotech (LEGN – Research Report), ...

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

1d ago, source: Benzinga.com

Shares of Teledyne Technologies Incorporated TDY fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS ...

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS)

14d ago, source:

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bausch Health Companies (BHC – Research Report) and Arcus ...

FDA pauses Watertown biotech’s schizophrenia trial

10d ago, source:

The U.S. Food and Drug Administration placed a clinical hold on a Watertown biotech’s schizophrenia drug trial after new ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...